Scribe Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCTX and other ETFs, options, and stocks.

About SCTX

Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. 

CEO
Benjamin L. Oakes, PhD
CEOBenjamin L. Oakes, PhD
Employees
98
Employees98
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
Founded
Employees
98
Employees98

SCTX Key Statistics

Market cap
357.95M
Market cap357.95M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
$25.49
High today$25.49
Low today
$22.00
Low today$22.00
Open price
$25.00
Open price$25.00
Volume
544.52K
Volume544.52K
52 Week high
52 Week high
52 Week low
52 Week low

Stock Snapshot

Scribe Therapeutics(SCTX) stock is priced at $22.12, giving the company a market capitalization of 357.95M.

During the trading session on 2026-07-24, Scribe Therapeutics(SCTX) shares reached a daily high of $25.49 and a low of $22.00. At a current price of $22.12, the stock is +0.5% higher than the low and still -13.2% under the high.

Trading volume for Scribe Therapeutics(SCTX) stock has reached 544.52K.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.